BRD2‐specific inhibitor, BBC0403, inhibits the progression of osteoarthritis pathogenesis in osteoarthritis‐induced C57BL/6 male miceHyemi Lee, Siyoung Yang|British Journal of Pharmacology|2024Cited by 6
A Novel BD2-Selective Inhibitor of BRDs Mitigates ROS Production and OA PathogenesisHyemi Lee, Siyoung Yang|Antioxidants|2024Cited by 4
A novel carboxamide bromodomain inhibitor attenuates osteoarthritis via epigenetic repression of NF-κB and MAPK signalingHyemi Lee, Siyoung Yang|Frontiers in Immunology|2025Cited by 1